Innovation Pharmaceuticals Inc (IPIX)

$0.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 377,014
Avg Vol 248,191
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 50%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Ce...

Industry: Biotechnology
Sector: Healthcare
Phone: 978 921 4125
Address:
301 Edgewater Place, Suite 100, Wakefield, United States
fit007
fit007 Jul. 30 at 1:54 PM
$IPIX Interesting article: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0325722
0 · Reply
harmeyerc
harmeyerc Jul. 21 at 7:22 PM
$IPIX The best-case scenario for IPIX shareholders is a 50–100x stock price increase to $0.025–$0.05 by 2026–2027, driven by BeaMed’s StingRay achieving FDA clearance and commercial success (valuing IPIX’s stake at $5–20M) and Brilacidin securing OM approval with a major partnership ($50–100M in payments). A potential $200–500M buyout by 2028–2029 could yield $0.40–$1.00 per share, turning a $10,000 investment into $800,000–$2M. This scenario assumes flawless execution by BeaMed and IPIX, sufficient funding, and strong market conditions. Shareholders should monitor BeaMed’s FDA submissions (Q2 2024), IPIX’s Brilacidin partnerships, and SEC filings (www.sec.gov) (www.sec.gov) for progress.
4 · Reply
Nik_CA
Nik_CA Jul. 21 at 4:48 AM
$IPIX some fun with chatgpt results A licensing or asset-share deal for brilacidin appears highly likely within 12–18 months. A full acquisition, while less probable, could materialize later once key Phase 3 data emerges and brilacidin proves its value.
1 · Reply
toolajittooquit
toolajittooquit Jul. 20 at 2:47 PM
$IPIX if they had only bought crypto currency
0 · Reply
Luka_Brasi
Luka_Brasi Jul. 18 at 3:11 PM
$IPIX Does anyone know if there's any actual operations or any employees besides executives? The usual course of these is to announce releasing a crypto coin to get some P&D action for excs.
1 · Reply
Highbank
Highbank Jul. 17 at 4:55 PM
$IPIX It's amazing to me that this ticker has not been suspended or revoked by this time. The last time we heard from Leo was in July 2023. Several stocks over the years that have been this far out of compliance with SEC filing have been suspended and revoked. Is behind-the-scenes money financing IPIX's continued existence?
2 · Reply
WallStreetIsNotEasy
WallStreetIsNotEasy Jul. 16 at 2:09 PM
$IPIX We will get paid as soon as Gilead is ready to write a very big check 👌
2 · Reply
fit007
fit007 Jul. 15 at 4:49 PM
$IPIX https://www.sciencedirect.com/science/article/pii/S2590262825000231
1 · Reply
fit007
fit007 Jul. 15 at 1:35 PM
$IPIX Another Gilead patent published today that mentions Brilacidin. https://ppubs.uspto.gov/api/pdf/downloadPdf/12357577?requestToken=eyJzdWIiOiJlZDliNzRiOS0yMjc1LTQ5YzctODU3NC01ODA0NzcxMjU4NDIiLCJ2ZXIiOiI5MDg5ZjJjZi1kMDU5LTRlY2ItYmUyMy02ODJkOGEwMjg5ZjIiLCJleHAiOjB9
2 · Reply
Tommyj1014
Tommyj1014 Jul. 7 at 9:41 PM
$IPIX Webull shows another 800k shares purchaed. 770k in a single transaction. Who is buying and does anyone one know how?
3 · Reply
Latest News on IPIX
No data available.
fit007
fit007 Jul. 30 at 1:54 PM
$IPIX Interesting article: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0325722
0 · Reply
harmeyerc
harmeyerc Jul. 21 at 7:22 PM
$IPIX The best-case scenario for IPIX shareholders is a 50–100x stock price increase to $0.025–$0.05 by 2026–2027, driven by BeaMed’s StingRay achieving FDA clearance and commercial success (valuing IPIX’s stake at $5–20M) and Brilacidin securing OM approval with a major partnership ($50–100M in payments). A potential $200–500M buyout by 2028–2029 could yield $0.40–$1.00 per share, turning a $10,000 investment into $800,000–$2M. This scenario assumes flawless execution by BeaMed and IPIX, sufficient funding, and strong market conditions. Shareholders should monitor BeaMed’s FDA submissions (Q2 2024), IPIX’s Brilacidin partnerships, and SEC filings (www.sec.gov) (www.sec.gov) for progress.
4 · Reply
Nik_CA
Nik_CA Jul. 21 at 4:48 AM
$IPIX some fun with chatgpt results A licensing or asset-share deal for brilacidin appears highly likely within 12–18 months. A full acquisition, while less probable, could materialize later once key Phase 3 data emerges and brilacidin proves its value.
1 · Reply
toolajittooquit
toolajittooquit Jul. 20 at 2:47 PM
$IPIX if they had only bought crypto currency
0 · Reply
Luka_Brasi
Luka_Brasi Jul. 18 at 3:11 PM
$IPIX Does anyone know if there's any actual operations or any employees besides executives? The usual course of these is to announce releasing a crypto coin to get some P&D action for excs.
1 · Reply
Highbank
Highbank Jul. 17 at 4:55 PM
$IPIX It's amazing to me that this ticker has not been suspended or revoked by this time. The last time we heard from Leo was in July 2023. Several stocks over the years that have been this far out of compliance with SEC filing have been suspended and revoked. Is behind-the-scenes money financing IPIX's continued existence?
2 · Reply
WallStreetIsNotEasy
WallStreetIsNotEasy Jul. 16 at 2:09 PM
$IPIX We will get paid as soon as Gilead is ready to write a very big check 👌
2 · Reply
fit007
fit007 Jul. 15 at 4:49 PM
$IPIX https://www.sciencedirect.com/science/article/pii/S2590262825000231
1 · Reply
fit007
fit007 Jul. 15 at 1:35 PM
$IPIX Another Gilead patent published today that mentions Brilacidin. https://ppubs.uspto.gov/api/pdf/downloadPdf/12357577?requestToken=eyJzdWIiOiJlZDliNzRiOS0yMjc1LTQ5YzctODU3NC01ODA0NzcxMjU4NDIiLCJ2ZXIiOiI5MDg5ZjJjZi1kMDU5LTRlY2ItYmUyMy02ODJkOGEwMjg5ZjIiLCJleHAiOjB9
2 · Reply
Tommyj1014
Tommyj1014 Jul. 7 at 9:41 PM
$IPIX Webull shows another 800k shares purchaed. 770k in a single transaction. Who is buying and does anyone one know how?
3 · Reply
fit007
fit007 Jul. 1 at 4:11 PM
$IPIX Interesting that they are still testing Kevetrin. https://pubmed.ncbi.nlm.nih.gov/40488714/
1 · Reply
Highbank
Highbank Jun. 27 at 1:19 PM
$IPIX Amazing study, as pointed out by fit007 on 6/6/25 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0325722
0 · Reply
fit007
fit007 Jun. 24 at 3:02 PM
$IPIX Posted by airplaneguy on hangout Brilacidin disassembles the outer coating of bacteria and viruses. In bacteria the pathogen cannot exist without it's cellular membrane. In viruses Brilacidin inhibits the protein spikes and other proteins the virus uses to gain cellular entry. The alpha virus outer protective coating (armor) is essentially "scattered in the wind" where the T-cell plus other phagocytes and B-cell epitopes will make short work of it. The drug resistant syphilis cannot exist without it spiral carbohydrate coating The outer membrane of syphillis (T. pallidum) contains carbohydrates, along with lipids and proteins. These are all easily disassembled by Brilacidin. Penicillin interferes with the syphilis bacteria's ability to build and maintain its cell wall. Brilacidin completely destroys it's cell wall in mere seconds, as it is a defensin protein and completely "shreds" the protective membrane and leaves the lipid layers in human cells intact. In does not cause inflammation.
4 · Reply
OhLordy
OhLordy Jun. 23 at 7:27 PM
$IPIX Having trouble holding these gains
3 · Reply
SmallCapGrowth
SmallCapGrowth Jun. 20 at 3:27 PM
$SHMN SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations https://www.stocktitan.net/news/SHMN/sohm-inc-welcomes-dr-larissa-karnaoukhova-as-new-vice-president-of-oc7nsi3nfwdy.html $ENZC $IPIX $
1 · Reply
fit007
fit007 Jun. 19 at 1:10 PM
$IPIX Another patent published by Gilead that mentions brilacidin. https://ppubs.uspto.gov/api/pdf/downloadPdf/20250197410?requestToken=eyJzdWIiOiJmODYxMDg4MC0yNDAyLTQwYmEtOWZmNy1lMmNmOWZjYTY5NGQiLCJ2ZXIiOiIzNTYzODc3My04M2YzLTQ4NjgtYjgzMy1iZTU5ODAxMjQyNzUiLCJleHAiOjB9
2 · Reply
Tommyj1014
Tommyj1014 Jun. 16 at 8:46 PM
$IPIX Who just bought 1 million shares, and how?
0 · Reply
fit007
fit007 Jun. 16 at 12:33 AM
$IPIX IPIX scientific advisor: https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.5c00396
1 · Reply
Tommyj1014
Tommyj1014 Jun. 11 at 8:27 PM
$IPIX .
0 · Reply
rodyar
rodyar Jun. 11 at 2:22 AM
$IPIX how are people buying this on expert market
1 · Reply
fit007
fit007 Jun. 10 at 5:29 PM
$IPIX https://figshare.com/articles/figure/The_high_safety_profile_of_brilacidin_/29248898?file=55155848
1 · Reply
toolajittooquit
toolajittooquit Jun. 10 at 2:21 PM
$IPIX nothing ever became of brilaciden. All those testing in labs and nothing to show for it.
1 · Reply